1-20 of 28
Melinda E. Sanders
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P1-04-03: Host myeloid response to tumor and immunotherapy is associated with heterogeneity in outcomes to anti-PDL1

Ann Hanna, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta M. Sanchez, Melinda E. Sanders, Justin M. Balko
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-04-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-04-03
Published: 15 February 2022
View article
Journal Articles

Abstract PD3-04: Multi-omics characterization of triple-negative breast cancer identifies therapeutic vulnerabilities and epigenetic immune suppression in the mesenchymal subtype

Brian D Lehmann, Antonio Colaprico, Tiago C Silva, Jianjiao Chen, Hanbing An, Yuguang Ban, Lily Wang, Jamaal L James, Justin Balko, Paula I Gonzalez-Ericsson, Melinda E Sanders, Bing Zhang, Jennifer A Pietenpol, Xi S Chen
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD3-04.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD3-04
Published: 15 February 2022
View article
Journal Articles

Abstract PD9-06: Peripheral blood gene signatures predict response to neoadjuvant chemotherapy in breast cancer patients

Margaret L Axelrod, Paula I Gonzalez-Ericsson, Xiaopeng Sun, Riley E Bergman, Joshua Donaldson, Sara M Tolaney, Ian E Krop, Ana C Garrido-Castro, Melinda E. Sanders, Ingrid A Mayer, Justin M Balko
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD9-06.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PD9-06
Published: 15 February 2021
View article
Journal Articles

Abstract PS17-14: Evaluating the efficacy of immunotherapy in triple negative breast cancer

Ann Hanna, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Justin M. Balko
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS17-14.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS17-14
Published: 15 February 2021
View article
Journal Articles

Abstract PD5-07: The immune landscape of residual triple-negative breast cancers after neoadjuvant chemotherapy

Paula I Gonzalez-Ericsson, Violeta Sanchez, Roberto Salgado, Jennifer Bordeaux, Ju Y Kim, Christine Vaupel, Henry Gomez, Melinda E Sanders, Justin M Balko
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD5-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-PD5-07
Published: 15 February 2020
View article
Journal Articles

Abstract P3-08-15: Immunologic correlates of long-term outcome in the residual disease of triple-negative breast cancer after neoadjuvant chemotherapy

Justin M Balko, Mellissa Nixon, Paula I Gonzalez-Ericsson, Mark A Pilkinton, Wyatt J McDonnell, Violeta Sanchez, Susan R Opalenik, Sherene Loi, Brent Rexer, Vandana Abramson, Valerie Jansen, Simon Mallal, Jonathan D Marotti, Kevin Shee, Todd W Miller, Melinda E Sanders, Ingrid A Mayer, Roberto Salgado
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P3-08-15.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P3-08-15
Published: 15 February 2020
View article
Journal Articles

Abstract 1511: MEK activation modulates immunosuppressive MDSCs and metabolic phenotypes in TNBC

Derek A. Franklin, Joe T. Sharick, Paula I. Ericsson-Gonzalez, Violeta Sanchez, Phillip T. Dean, Susan R. Opalenik, Stefano Cairo, Jean-Gabriel Judde, Michael T. Lewis, Jenny C. Chang, Melinda E. Sanders, Rebecca S. Cook, Melissa C. Skala, Jennifer Bordeaux, Jehovana Orozco Bender, Christine Vaupel, Gary Geiss, Douglas Hinerfeld, Justin M. Balko
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1511.
DOI: https://doi.org/10.1158/1538-7445.AM2019-1511
Published: 01 July 2019
View article
Journal Articles

Correction: Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer, Luigi Formisano, Kyung-Min Lee, Katherine E. Hutchinson, Agnieszka K. Witkiewicz, Preston D. Moore, Mónica Valéria Estrada, Violeta Sánchez, Paula G. Ericsson, Melinda E. Sanders, Paula R. Pohlmann, Michael J. Pishvaian, David A. Riddle, Teresa C. Dugger, Wenyi Wei, Erik S. Knudsen, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2019) 79 (4): 874.
DOI: https://doi.org/10.1158/0008-5472.CAN-18-4086
Published: 15 February 2019
View article
PDF
Journal Articles

Correction: Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer

Ariella B. Hanker, Mónica Valeria Estrada, Giampaolo Bianchini, Preston D. Moore, Junfei Zhao, Feixiong Cheng, James P. Koch, Luca Gianni, Darren R. Tyson, Violeta Sánchez, Brent N. Rexer, Melinda E. Sanders, Zhongming Zhao, Thomas P. Stricker, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2019) 79 (4): 873.
DOI: https://doi.org/10.1158/0008-5472.CAN-18-4085
Published: 15 February 2019
View article
PDF
Journal Articles

Abstract 2982: Somatic TP53 mutations alter the immune microenvironmentafter chemotherapy in breast cancer

Mellissa J. Nixon, V. Monica Estrada, Susan R. Opalenki, Donna Hicks, Michael Korrer, Melinda E. Sanders, Roberto Salgado, Young Kim, Rebecca Cook, Carlos L. Arteaga, Justin M. Balko
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2982.
DOI: https://doi.org/10.1158/1538-7445.AM2018-2982
Published: 01 July 2018
View article
Journal Articles

Abstract 2398: Tumor cell-adipocyte gap junctions activate lipolysis in breast cancer

Roman Camarda, Jeremy Williams, Serghei Malkov, Lisa J. Zimmerman, Suzanne Manning, Dvir Aran, Andrew Beardsley, Daniel Van de Mark, Jeffrey van Haren, Yong Chen, Charles Berdan, Sharon Louie, Celine Mahieu, Juliane Winkler, Elizabeth Willey, John D. Gagnon, Kosaku Shinoda, K. Mark Ansel, Zena Werb, Daniel C. Nomura, Shingo Kajimura, Torsten Wittmann, Atul J. Butte, Melinda E. Sanders, Daniel C. Liebler, Gregor Krings, John A. Shepherd, Andrei Goga
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2398.
DOI: https://doi.org/10.1158/1538-7445.AM2018-2398
Published: 01 July 2018
View article
Journal Articles

Abstract 1008: Gain-of-function kinase library screen identifies FGFR1 amplification as a mechanism of resistance to antiestrogens and CDK4/6 inhibitors in ER+ breast cancer

Luigi Formisano, Yao Lu, Valerie M. Jansen, Joshua A. Bauer, Ariella B. Hanker, Melinda E. Sanders, Paula González-Ericsson, Sunkyu Kim, Monica Arnedos, Fabrice André, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1008.
DOI: https://doi.org/10.1158/1538-7445.AM2017-1008
Published: 01 July 2017
View article
Journal Articles

Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer

Ariella B. Hanker, Mónica Valeria Estrada, Giampaolo Bianchini, Preston D. Moore, Junfei Zhao, Feixiong Cheng, James P. Koch, Luca Gianni, Darren R. Tyson, Violeta Sánchez, Brent N. Rexer, Melinda E. Sanders, Zhongming Zhao, Thomas P. Stricker, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2017) 77 (12): 3280–3292.
DOI: https://doi.org/10.1158/0008-5472.CAN-16-2808
Published: 14 June 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer, Luigi Formisano, Kyung-Min Lee, Katherine E. Hutchinson, Agnieszka K. Witkiewicz, Preston D. Moore, Mónica Valéria Estrada, Violeta Sánchez, Paula G. Ericsson, Melinda E. Sanders, Paula R. Pohlmann, Michael J. Pishvaian, David A. Riddle, Teresa C. Dugger, Wenyi Wei, Erik S. Knudsen, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2017) 77 (9): 2488–2499.
DOI: https://doi.org/10.1158/0008-5472.CAN-16-2653
Published: 30 April 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 4241: Predicting clinical response in breast cancer using cellular-resolution optical metabolic imaging

Joe T. Sharick, Alex J. Walsh, Melinda E. Sanders, Ingrid Meszoely, Mary A. Hooks, Mark C. Kelley, Melissa C. Skala
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4241.
DOI: https://doi.org/10.1158/1538-7445.AM2016-4241
Published: 15 July 2016
View article
Journal Articles

Abstract 2000: Proteomic features of histological compartments in colorectal carcinoma

Robbert JC Slebos, Lisa J. Zimmerman, Suzanne Manning, Melinda E. Sanders, Chanjuan Shi, M Kay Washington, Daniel C. Liebler
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2000.
DOI: https://doi.org/10.1158/1538-7445.AM2015-2000
Published: 01 August 2015
View article
Journal Articles

Abstract P6-03-03: Enrichment of janus kinase-2 (JAK2)-amplified tumor cell populations in triple-negative breast cancers (TNBC) during chemotherapy treatment

Luis J Schwarz, Justin M Balko, Jennifer M Giltnane, Monica V Estrada, Melinda E Sanders, Kai Wang, Nancy U Lin, Vicent A Miller, Philip Stephens, Roman Yelensky, Joseph A Pinto, Henry L Gómez, Melissa D Landis, Jenny C Chang, Carlos L Arteaga
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P6-03-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-P6-03-03
Published: 01 May 2015
View article
Journal Articles

Abstract P3-04-03: PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

Brian D Lehmann, Joshua A Bauer, Johanna M Schafer, Christopher S Pendleton, Luojia Tang, Kimberly C Johnson, Xi Chen, Justin M Balko, Henry Gomez, Carlos L Arteaga, Gordon B Mills, Melinda E Sanders, Jennifer A Pietenpol
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P3-04-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-P3-04-03
Published: 01 May 2015
View article
Journal Articles

Abstract P3-06-38: Optical metabolic imaging predicts therapeutic response in breast cancer tumors and organoids

Alex J Walsh, Rebecca S Cook, Melinda E Sanders, Carlos L Arteaga, Melissa C Skala
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P3-06-38.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-P3-06-38
Published: 01 May 2015
View article
Journal Articles

Abstract P3-06-32: Genetic heterogeneity for Her2 accounts for a significant percentage of breast cancers changing Her2 status following implementation of the 2013 CAP/ASCO HER2 reporting guidelines

Monica V Estrada, Jena M Giltnane, Ferrin C Wheeler, Ashwini Yenamandra, Vandana Abramson, Ingrid A Mayer, Julie Means, Brent Rexer, Ingrid M Meszoely, Melinda E Sanders
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P3-06-32.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-P3-06-32
Published: 01 May 2015
View article